Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Drug Investigation|August 12, 2024
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell DiseaseKhadidja Abdallah, Isabelle Huys, Kathleen J Claes, et al.
Acta Clinica Belgica|June 17, 2025
Sjögren's disease with mixed cryoglobulinemia presenting as a hypertensive emergency with thrombotic microangiopathy: a diagnostic puzzleHanne Reynaert, Priyanka Koshy, Xavier Bossuyt, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2013
Sclerostin: Another vascular calcification inhibitor?Kathleen J Claes, Liesbeth Viaene, Sam Heye, et al.
Acta Clinica Belgica|November 30, 2025
Navigating complexities: differential diagnosis of thrombotic microangiopathies in pregnancy - a case reportMaxim Bobbaerts, Lore Lannoo, Daan Dierickx, et al.
Pediatric Nephrology (Berlin, Germany)|May 10, 2015
Management dilemmas in pediatric nephrology: CystinosisMartine T P Besouw, Maria Van Dyck, David Cassiman, et al.
American Journal of Nephrology|December 7, 2011
Impact of vascular calcification on corrected QT interval at the time of renal transplantationKathleen J Claes, Sam Heye, Dieter Nuyens, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 7, 2022
Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case ReportKathleen J Claes, Inge Geerts, Wim Lemahieu, et al.
Transplantation Direct|March 13, 2025
Thrombotic Microangiopathy: A Devastating Complication After Lung TransplantationWouter Rosseels, Laurent Godinas, Papay Jallah, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 23, 2013
Aortic calcifications and arterial stiffness as predictors of cardiovascular events in incident renal transplant recipientsKathleen J Claes, Sam Heye, Bert Bammens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2013
Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcomeThomas Vanhove, Dirk Kuypers, Kathleen J Claes, et al.
Pageof 3